Intracellular lipid levels were detected using BODIPY FL Dye (GC42959
[DOI] [PubMed] [Google Scholar] 54.Fujinaga A, Ohta M, Endo Y, Nakanuma H, Kawamura M, Hirashita Y, Kawasaki T, Masuda T, Hirashita T, Gotoh K, Inomata M
Type: Synthetic triple-agonist peptide Receptors Targeted: GLP1R, GIPR, and GCGR Mechanism of Action: Appetite suppression, enhanced insulin response, increased energy expenditure Delivery: Once-weekly subcutaneous injection Research Use: Preclinical and clinical studies in obesity, metabolic disorders, and type 2 diabetes Retatrutide is a next-generation multi-receptor peptide that leverages GLP1, GIP, and glucagon signaling to produce weight loss and metabolic benefits
Yes, combining Ozempic and Jardiance is generally considered safe and is a recognized approach in diabetes and cardiometabolic management